[Department of Error] Department of Error
Goette A, Merino JL, Ezekowitz MD, et al. Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. Lancet 2016; 388: 1995–2003—The author list of this Article has been updated to include the ENSURE-AF investigators. In the first sentence in summary, “well controlled enoxaparin–warfarin therapy” should have read “well controlled warfarin therapy”. The webappendix of this Article has also been corrected. These corrections have been made to the online version as of Oct 20, 2016, and the printed Article is correct.